# FDA Inspection 1297464 - LGC Clinical Diagnostics, Inc. - December 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/lgc-clinical-diagnostics-inc/3289bbec-580b-4dfc-9287-e9aa7208ca6b
Source feed: FDA_Inspections

> FDA Inspection 1297464 for LGC Clinical Diagnostics, Inc. on December 10, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1297464
- Company Name: LGC Clinical Diagnostics, Inc.
- Inspection Date: 2025-12-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1297464 - 2025-12-10](https://www.keypedia.com/records/fda_inspections/lgc-clinical-diagnostics-inc/00b77e51-2e1f-4d56-9159-e61867d32e58)
- [FDA Inspection 775644 - 2012-03-28](https://www.keypedia.com/records/fda_inspections/lgc-clinical-diagnostics-inc/a74b625b-89d4-4fe8-8b25-e63a6b46034d)
- [FDA Inspection 733038 - 2011-06-28](https://www.keypedia.com/records/fda_inspections/lgc-clinical-diagnostics-inc/bdd9c2b2-bb9e-4fb2-b28b-2ef5ec395d27)

Company: https://www.keypedia.com/companies/lgc-clinical-diagnostics-inc/bdc534cf-de5d-4945-a219-951d10848494

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d